USANA Health Sciences, Inc. (NYSE:USNA) Shares Bought by Principal Financial Group Inc.

Principal Financial Group Inc. grew its position in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 2.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 53,603 shares of the company’s stock after acquiring an additional 1,480 shares during the quarter. Principal Financial Group Inc. owned about 0.28% of USANA Health Sciences worth $1,924,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Pzena Investment Management LLC grew its stake in shares of USANA Health Sciences by 7.5% in the third quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock valued at $39,801,000 after buying an additional 72,977 shares in the last quarter. Pacer Advisors Inc. grew its stake in shares of USANA Health Sciences by 8.8% in the fourth quarter. Pacer Advisors Inc. now owns 592,001 shares of the company’s stock valued at $21,247,000 after buying an additional 47,745 shares in the last quarter. State Street Corp grew its stake in shares of USANA Health Sciences by 0.6% in the third quarter. State Street Corp now owns 435,164 shares of the company’s stock valued at $16,501,000 after buying an additional 2,782 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of USANA Health Sciences by 4.5% in the third quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock valued at $11,269,000 after buying an additional 12,898 shares in the last quarter. Finally, Nordea Investment Management AB grew its stake in shares of USANA Health Sciences by 5.7% in the fourth quarter. Nordea Investment Management AB now owns 50,450 shares of the company’s stock valued at $1,814,000 after buying an additional 2,723 shares in the last quarter. 54.25% of the stock is currently owned by institutional investors and hedge funds.

USANA Health Sciences Trading Up 4.2 %

USNA stock opened at $30.86 on Thursday. The firm has a 50 day simple moving average of $33.20 and a 200-day simple moving average of $36.34. The company has a market capitalization of $588.10 million, a P/E ratio of 10.90, a PEG ratio of 0.93 and a beta of 0.98. USANA Health Sciences, Inc. has a twelve month low of $27.71 and a twelve month high of $50.32.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.15. The company had revenue of $213.61 million during the quarter, compared to analyst estimates of $208.82 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. On average, research analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insiders Place Their Bets

In other USANA Health Sciences news, CEO Jim Brown sold 5,000 shares of the firm’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $29.47, for a total transaction of $147,350.00. Following the completion of the transaction, the chief executive officer now directly owns 15,716 shares of the company’s stock, valued at $463,150.52. This trade represents a 24.14 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

USNA has been the subject of a number of recent research reports. DA Davidson lowered their target price on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a research note on Thursday, February 27th. Sidoti lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. Finally, StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.